Search

everythinglearnresearchcommunity

for

Search:↓

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Tamoxifen caused hair loss in a 52-year-old woman.

Europe needs a clear system to watch over cosmetics for safety and to make sure product claims are true.

Breast cancer may be detectable through changes in scalp hair lipids.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Nanoparticle systems make cancer treatment less toxic.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Puerto Rican children with cancer often experience symptoms like irritability, nausea, and hair loss, and need better education and continuous symptom management.

The document concludes that modern photo stories help represent and challenge how breast cancer affects women's identities and societal norms.

PCOD mainly affects young women, causing symptoms like irregular periods and weight gain, with mixed success from lifestyle changes and medication.

A group has developed therapies that show promise for treating cancer and various other conditions.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

Nutritional education reduces chemotherapy side effects and improves health in breast cancer patients.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Older skin has higher cancer risk due to inflammation and stem cell issues.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.